12 Questions
What is a potential strategy to mitigate the risks of contrast-induced nephrotoxicity and nephrogenic systemic fibrosis in patients with renal insufficiency?
Using screening and selection strategies
Why is it not recommended to restrict contrast medium use solely based on a patient's cardiac status?
It is not effective in reducing non-allergic cardiac events
Which group of patients is believed to have lower reaction rates to contrast medium injections?
Infants, neonates, children, and the elderly
What patient characteristic is associated with higher rates of contrast reactions according to the text?
Female gender
How might anxiety impact the likelihood of a mild contrast reaction according to the text?
Reduce the likelihood of a mild reaction
What are some cardiac conditions that may increase the risk of a non-allergic cardiac event if a contrast reaction occurs?
Severe aortic stenosis and cardiac arrhythmias
What does the text recommend regarding the restriction of contrast medium use based on patient age or gender?
Do not restrict contrast medium use based on patient age or gender.
How does the use of beta-blockers impact contrast reactions, according to the text?
Lowers the threshold for contrast reactions.
What is the recommendation regarding discontinuing beta-blocker therapy prior to contrast medium administration?
Discontinuation of beta-blockers is not necessary before contrast medium administration.
What is the stance on restricting contrast medium use based on pheochromocytoma history?
Do not restrict contrast medium based on a history of pheochromocytoma.
What does the text suggest about using modern iodinated or gadolinium-based contrast medium in patients with myasthenia gravis?
Use iodinated or gadolinium-based contrast medium cautiously in patients with myasthenia gravis.
What does the text say about the risk of developing thyrotoxic symptoms in patients with a history of hyperthyroidism?
There is no evidence to suggest an increased risk of thyrotoxic symptoms in these patients.
Learn about screening and selection strategies to reduce the risks of contrast-induced nephrotoxicity and nephrogenic systemic fibrosis. Explore the impact of severe cardiac disease on non-allergic cardiac events during contrast administration.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
